Lipid Peroxidation Regulators GPX4 and FSP1 as Prognostic Markers and Therapeutic Targets in Advanced Gastric Cancer
Authors:
- Kazuhiro TamuraKTKazuhiro Tamura
- Yoshinobu TomitaYTYoshinobu Tomita
- Takumi KanazawaTKTakumi Kanazawa
- Hajime ShinoharaHSHajime Shinohara
- Masayoshi SakanoMSMasayoshi Sakano
- Sachiko IshibashiSISachiko Ishibashi
- Masumi IkedaMIMasumi Ikeda
- Mayumi KinoshitaMKMayumi Kinoshita
- Junko MinamiJMJunko Minami
- Kurara YamamotoKYKurara Yamamoto
- Yuki KatoYKYuki Kato
- Asuka FurukawaAFAsuka Furukawa
Open Access
- 24 August 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (17) , 9203
Abstract
Gastric cancer is one of the most common cancers worldwide, and new therapeutic strategies are urgently needed. Ferroptosis is an intracellular iron-dependent cell death induced by the accumulation of lipid peroxidation, a mechanism different from conventional apoptosis and necrosis. Therefore, induction of ferroptosis is expected to be a new therapeutic strategy. Glutathione peroxidase 4 (GPX4) and ferroptosis suppressor protein 1 (FSP1) have been identified as the major inhibitors of ferroptosis. Herein, we performed immunohistochemistry for GPX4, FSP1, and 4-HNE using tissues from patients with gastric cancer and investigated the relationship between these factors and prognosis. Patients with high GPX4 expression or high GPX4 expression and low 4-HNE accumulation tended to have a poor prognosis (p = 0.036, 0.023), whereas those with low FSP1 expression and high 4-HNE accumulation had a good prognosis (p = 0.033). The synergistic induction of cell death by inhibiting GPX4 and FSP1 in vitro was also observed, indicating that the cell death was non-apoptotic. Our results indicate that the expression and accumulation of lipid peroxidation-related factors play an important role in the clinicopathological significance of gastric cancer and that novel therapeutic strategies targeting GPX4 and FSP1 may be effective in treating patients with gastric cancer who have poor prognosis.Keywords
This publication has 30 references indexed in Scilit:
- Mediation of Ferroptosis Suppressor Protein 1 Expression via 4-Hydroxy-2-Nonenal Accumulation Contributes to Acquisition of Resistance to Apoptosis and Ferroptosis in Diffuse Large B-Cell LymphomaLaboratory Investigation, 2024
- Overexpression of ferroptosis-related genes FSP1 and CISD1 is related to prognosis and tumor immune infiltration in gastric cancerClinical and Translational Oncology, 2023
- Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)Gastric Cancer, 2022
- Stratification of lung squamous cell carcinoma based on ferroptosis regulators: Potential for new therapeutic strategies involving ferroptosis inductionLung Cancer, 2022
- Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosisJournal of Natural Medicines, 2021
- Review of iron-free Fenton-like systems for activating H2O2 in advanced oxidation processesJournal of Hazardous Materials, 2014
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Matrix metalloproteinases and tumor metastasisCancer and Metastasis Reviews, 2006
- Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxideArchives of Biochemistry and Biophysics, 1991